Key result
Medtronic HVAD implantation succeeds as a bridge-to-candidacy in 2 pediatric patients with restrictive cardiomyopathy.
Why the study?
Whether left ventricular assist devices can reverse pulmonary hypertension in paediatric patients with restrictive cardiomyopathy was uncertain.
Does left ventricular assist device implantation reverse pulmonary hypertension in paediatric patients with restrictive cardiomyopathy?
Case Report (n=2)
Does left ventricular assist device implantation reverse pulmonary hypertension in paediatric patients with restrictive cardiomyopathy?
Implantation of a left ventricular assist device may be a feasible bridge-to-candidacy strategy for reversing pulmonary hypertension in pediatric patients with restrictive cardiomyopathy.
Supports HVAD feasibility as bridge-to-candidacy in pediatric restrictive cardiomyopathy; hypothesis-generating for pulmonary hypertension reversal.
Left ventricular assist devices can reverse pulmonary hypertension in cardiac transplant candidates with heart failure with a reduced ejection fraction. Whether a similar approach is applicable in restrictive cardiomyopathy is uncertain. We report the successful implantation of a Medtronic HVAD left ventricular assist device in a bridge-to-candidacy concept in 2 paediatric patients with restrictive cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Schlein et al. (2021) conducted a case report in Restrictive cardiomyopathy (n=2). Medtronic HVAD left ventricular assist device was evaluated on Successful implantation in a bridge-to-candidacy concept. Implantation of a Medtronic HVAD left ventricular assist device was successful in a bridge-to-candidacy concept in 2 paediatric patients with restrictive cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: